week 4 tirzepatide maintenance with @morphwellnessmd is in the books!, #morphwellnessmd #morphyourself #morphmd #morphhealthandwellness , #WeightLossJourney #Tirzepatide #gethealthywithme In the SURMOUNT-4 trial, 82.5%

EMD-23922), and c-MET/NK1 (7MOB

Key review points include RUO labeling, batch-specific COA records, lot traceability, peptide purity data, peptide identity support, and supplier documentation consistency

Therefore, a prospective registry study or randomized pragmatic trial that can measure all relevant information more accurately and ensure a more inclusive patient population may be necessary to further confirm these findings

Recruitment for this study has been completed at the time of writing but results are pending (86)

Oral tirzepatide is in clinical trials, and if successful, could eliminate the injection barrier entirely for this class